Although mechanisms of the insulin mimetic effect of vanadium complexes still have to be clarified, their ability to sensitize peripheral tissues to insulin and to reduce insulin resistance attracts significant attention in the context of their potential use for the treatment of Diabetes Type 1 (DM1), Diabetes Type 2 (DM2) and obesity [6], [7]. Here, INS is linked to myotonic dystrophy type 2.